YOLFTbeta
Qlucore AB

Qlucore AB

QCORE · ST · Technology / Software - Application

0.32SEK+0.00 (0.00%)

Price History

Full chart

Market Stats

Previous Close0.32
Open0.321
Day Range0.32 – 0.321
52-Week Range0.213 – 0.58
Volume46.86K
Market Cap15.66M
P/E (TTM)0.51
Forward P/E0.00
EPS0.72
Dividend Yield0.00%
Beta0.39
50-Day Avg0.3942
200-Day Avg0.415

About

Qlucore AB (publ) offers visualization-based bioinformatics data analysis tools for research and precision diagnostics in Sweden and internationally. It offers Qlucore Omics Explorer, a bioinformatics software for research in life science, biotech, and plant industries, as well as academia; Qlucore Insights, a software for clinical data analysis; and Qlucore Diagnostics, a software platform for multi-omics companion. The company was incorporated in 2007 and is headquartered in Lund, Sweden.

Company Details

  • SectorTechnology
  • IndustrySoftware - Application
  • CEOMr. Carl-Johan Ivarsson MSc
  • Employees12
  • HeadquartersIdeon Science Park, Lund, Sweden, 223 70, Sweden
  • Websitehttps://www.qlucore.com

Leadership

  • Mr. Carl-Johan Ivarsson MScCo-Founder, Chair of Scientific Advisory Board & CEO
  • Mr. Thoas Fioretos M.D., Ph.D.Co-Founder & Member of Scientific Advisory Board · b. 1962
  • Mr. Johan RadeCo-Founder
  • Ms. Cecilia GrotteChief Financial Officer
  • Maria Falck MiniotisMarketing & Communications Manager
  • Mr. Erik SoderbackHead of Diagnostics Sales
  • Mr. Per NordqvistHead of Quality

Financials

Income Statement

Currency: SEK2019-04-302020-04-302021-04-302022-04-302023-04-302024-04-302025-04-302026-04-30
Total Revenue14.89M16.03M12.94M14.12M12.67M14.37M10.21M6.74M
Growth (%)-+7.66%-19.26%+9.08%-10.24%+13.39%-28.96%-34.00%
Cost of Revenue9.46M7.37M8.52M8.69M6.87M6.97M19.96M27.25M
Gross Profit5.43M8.66M4.42M5.43M5.80M7.40M-9.75M-20.51M
Gross Margin36.46%54.04%34.15%38.44%45.80%51.49%-95.50%-304.48%
Operating Expense5.94M7.25M9.98M16.92M22.11M24.22M10.77M7.50M
Operating Income-506.00K1.42M-5.56M-11.49M-16.30M-16.82M-20.51M-28.01M
Operating Margin-3.40%8.84%-42.99%-81.39%-128.67%-117.07%-200.96%-415.75%
EBITDA1.20M3.60M-5.45M-11.21M-15.30M-14.98M-15.44M-20.43M
EBITDA Margin8.08%22.43%-42.11%-79.44%-120.74%-104.28%-151.29%-303.27%
Net Income-633.61K1.23M-6.04M-11.66M-15.94M-15.68M-20.54M-36.52M
Net Income Margin-4.25%7.65%-46.63%-82.61%-125.76%-109.13%-201.17%-542.13%
R&D-2.06M2.50M3.22M3.44M---
R&D as % of Total Revenue-12.84%19.30%22.81%27.15%---
Interest Expense0144.00K389.00K140.00K297.00K353.00K447.00K194.00K
Interest Expense % of Total Revenue0.00%0.90%3.01%0.99%2.34%2.46%4.38%2.88%

Balance Sheet

Currency: SEK2019-04-302020-04-302021-04-302022-04-302023-04-302024-04-302025-04-302026-04-30
Total Assets17.57M22.79M46.24M121.90M109.36M90.01M69.95M42.01M
Total Liabilities9.01M8.45M9.68M11.34M14.63M10.90M11.49M5.71M
Total Equity8.56M14.34M36.56M110.56M94.73M79.11M58.47M36.30M
Cash2.31M4.47M27.56M97.97M69.73M28.62M5.26M2.97M
Total Debt3.50M4.71M4.63M5.33M4.46M3.18M2.00M1.40M
Net Debt1.19M236.00K-22.92M-92.64M-65.27M-25.44M-3.26M-1.57M

Cash Flow

Currency: SEK2019-04-302020-04-302021-04-302022-04-302023-04-302024-04-302025-04-302026-04-30
Operating Cash Flow1.60M1.60M-1.08M-6.81M-8.05M-16.95M-14.15M-12.46M
Investing Cash Flow-4.36M-4.36M-4.16M-8.95M-19.02M-22.52M-8.22M-3.67M
Financing Cash Flow3.71M3.71M28.28M86.25M-808.00K-1.27M-1.18M13.79M
Capital Expenditure129.00K4.36M4.16M8.95M19.02M22.52M8.22M47.00K
Free Cash Flow--2.76M-5.24M-15.76M-27.06M-39.47M-22.38M-12.51M
FCF to OCF--172.39%485.19%231.50%336.24%232.89%158.09%100.38%

Earnings

Report DateJan 31, 2022Apr 30, 2022Jul 31, 2022Oct 31, 2022Jan 31, 2023Apr 30, 2023Jul 31, 2023Oct 31, 2023Jan 31, 2024Apr 30, 2024Jul 31, 2024Oct 31, 2024Jan 31, 2025Apr 30, 2025Jul 31, 2025Oct 31, 2025Jan 31, 2026Apr 30, 2026Jul 31, 2026
EPS Estimate-------------------
EPS Actual0.05-0.47-0.61-0.52-0.37-0.51-0.63-0.41-0.35-0.59-0.95-0.75-0.65-0.24-0.83-0.78-0.08-0.08-0.07
Surprise-------------------
Timing-------------------

Key Statistics & Ratios

Market Cap15.66M
Enterprise Value10.64M
Trailing P/E0.51
Forward P/E0.00
Price / Sales1.39
Price / Book0.46
EPS0.72
Book Value0.846
Revenue (TTM)11.25M
Gross Profit (TTM)-3.79M
EBITDA-33.13M
Profit Margin-291.15%
Operating Margin-165.96%
Return on Equity-76.81%
Return on Assets-37.13%
Shares Outstanding42.90M
Shares Float13.15M
Beta0.39
Dividend Yield0.00%
Dividend Rate0.00
Payout Ratio0.00%